NLS PHARMACEUTICS LTD (NLSPW)
Institutional ownership reported to the SEC as of Q3 2025, across 19 quarters.
3
Reporting holders
$1.8K
Reported value
0.0%
Held as options
+0
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| Clear Street Group Inc. | $1.0K | 57,762 | 0.00% | new | FIRST |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $731 | 45,830 | 0.00% | 2q | +180.6% |
| UBS Group AG | $8 | 424 | 0.00% | new | NEW |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q3 2025 | 3 | $1.8K | 104,016 | 1 | 1 | 0 | 0.0% |
| Q2 2025 | 3 | $1.7K | 86,595 | 1 | 0 | 0 | 0.0% |
| Q1 2025 | 3 | $1.1K | 88,523 | 0 | 0 | 2 | 0.0% |
| Q4 2024 | 5 | $5.2K | 405,756 | 1 | 1 | 1 | 0.0% |
| Q3 2024 | 5 | $3.8K | 311,724 | 0 | 1 | 2 | 0.0% |
| Q2 2024 | 6 | $28.3K | 836,500 | 1 | 0 | 2 | 0.0% |
| Q1 2024 | 6 | $37.6K | 827,148 | 1 | 2 | 0 | 0.0% |
| Q4 2023 | 5 | $45.4K | 809,500 | 1 | 0 | 2 | 0.0% |
| Q3 2023 | 5 | $113.5K | 1,078,700 | 0 | 1 | 0 | 0.0% |
| Q2 2023 | 5 | $104.2K | 978,700 | 0 | 0 | 1 | 0.0% |
| Q1 2023 | 5 | $161.8K | 1,078,701 | 1 | 1 | 0 | 0.0% |
| Q4 2022 | 6 | $501.0K | 973,845 | 0 | 0 | 2 | 47.9% |
| Q3 2022 | 8 | $534.0K | 1,963,068 | 1 | 0 | 0 | 9.2% |
| Q2 2022 | 8 | $273.0K | 1,327,041 | 0 | 0 | 0 | 36.3% |
| Q1 2022 | 9 | $1.7M | 1,329,541 | 2 | 0 | 2 | 70.6% |
| Q4 2021 | 8 | $1.7M | 1,274,665 | 1 | 0 | 0 | 55.1% |
| Q3 2021 | 7 | $2.8M | 940,045 | 0 | 1 | 2 | 73.0% |
| Q2 2021 | 7 | $1.7M | 945,309 | 2 | 2 | 0 | 49.9% |
| Q1 2021 | 5 | $886.0K | 932,679 | 5 | 0 | 0 | 0.0% |